Results 61 to 70 of about 4,530 (177)

Postural Control Deficits in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Undergoing Immunomodulatory Therapy

Muscle &Nerve, Volume 74, Issue 1, Page 68-76, July 2026.
ABSTRACT Introduction/Aims Despite individuals with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) often reporting impaired balance as a main concern, there is a lack of research characterizing balance impairments or evaluating whether immunomodulatory therapy improves balance.
Heather Pudwell, Kyle J. Missen, Katie Beadon, Kristine M. Chapman, Emmanuel Ogalo, Chelsea B. Smith, Michael J. Berger, Mark G. Carpenter   +7 more
wiley   +1 more source

Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment

Neurology and Therapy
Introduction Subcutaneous immunoglobulin (SCIG) is a recommended maintenance treatment option for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and could offer greater patient convenience than intravenous immunoglobulin (IVIG).
Min Yang, Miriam L. Zichlin, Chelsey Fix, Danni Yang, Mo Zhou, Lisa Butler, Hakan Ay, Colin Anderson-Smits   +7 more
doaj   +1 more source

Usefulness of Information and Communication Technology‐Based Patient Information Sharing System in Supporting Patients With Intractable Neurological Diseases

Neurology and Clinical Neuroscience, Volume 14, Issue 4, Page 268-277, July 2026.
ABSTRACT Background Multidisciplinary collaboration is crucial for patients with incurable neurological diseases. However, sharing information among medical staff across institutions is challenging. Our cloud‐based patient information sharing system uses information and communication technology to facilitate the sharing of patient information among ...
Yui Kamijo, Akiyo Hineno, Gaku Okumura, Yoshiki Sekijima, Akinori Nakamura   +4 more
wiley   +1 more source

A rare presentation of acute-onset chronic inflammatory demyelinating polyneuropathy with the detection of anti-GM3 and anti-sulfatides antibodies: a case report

Frontiers in Immunology
ObjectivesChronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated neuropathy defined by clinical progression for more than 2 months. 16-20% of CIDP patients may present with rapidly progressive weakness that resembles GBS,
Ruohan Sun, Ruohan Sun, Yao Meng, Lingyu Li, Wei-hong Chen, Jing Xu, Peiyuan Lv, Peiyuan Lv, Yanhong Dong, Yanhong Dong   +9 more
doaj   +1 more source

Serological indication of chronic inflammatory demyelinating polyneuropathy as an extrahepatic manifestation of hepatitis E virus infection

Scientific Reports
Guillain–Barré syndrome and neuralgic amyotrophy have been associated with hepatitis E virus (HEV) genotype 3 infections, while myasthenia gravis (MG) has been associated with HEV genotype 4 infections. However, whether chronic inflammatory demyelinating
S. Pischke, A. Kjasimov, T. Skripuletz, C. Casar, J. Bannasch, M. Mader, S. Huber, F. Konen, A. Wolski, T. Horvatits, S. Gingele, S. Peine, J. Hiller, T. Seeliger, G. Thayssen, M. Lütgehetmann, J. Schulze zur Wiesch, A. Golsari, M. Gelderblom   +18 more
doaj   +1 more source

Antena sinuosa para radio monitoreo de 2 GHZ a 15 GHZ

Telemática, 2019
Con el objetivo de explorar la banda de frecuencias 2 GHz – 15 GHz con una sola antena de banda ancha, evitar el uso de varias antenas y conmutador de antenas correspondiente, se procedió al diseño y simulación de una antena sinuosa impresa.
Oniet Paz Barros, Pedro Arzola Morris, José Sandianes Gálvez   +2 more
doaj  

Dynametric assessment in CIDP [PDF]

Muscle & Nerve, 2009
In this issue, Harbo and colleagues,3 use a number of common measures, including manual muscle testing, as done in the Neuropathy Impairment Score (NIS), attributes of nerve conduction (NCs), quantitative sensation testing (QST) using CASE IV, functional activity scales (9-hole peg and 40-meter walk), and short SF-36 quality of life scales for ...
openaire   +1 more source

Efficacy of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy with or without diabetes: insights from a multicenter prospective comparative study

Therapeutic Advances in Neurological Disorders
Background: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is the most frequently observed autoimmune neuropathy in patients with diabetes mellitus (DM). While intravenous immune globulin (IVIG) is a well-established treatment for CIDP,
Samir P. Macwan, Shalini Mahajan, Peter Novak, Khosro Farhad, Ericka Wong, Thomas H. Brannagan, Sohail Masood, Fawad Piracha, Marinos C. Dalakas   +8 more
doaj   +1 more source

Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world study

Frontiers in Neurology
BackgroundRefractory chronic inflammatory demyelinating polyneuropathy (CIDP) is a challenging subset of CIDP. It does not respond well to immune therapy and causes substantial disability.
Yongsheng Zheng, Yongsheng Zheng, Yongsheng Zheng, Jianian Hu, Jianian Hu, Jianian Hu, Chong Sun, Chong Sun, Chong Sun, Kai Qiao, Yanyin Zhao, Yanyin Zhao, Yanyin Zhao, Bingyou Liu, Jian Sun, Jianying Xi, Jianying Xi, Jianying Xi, Sushan Luo, Sushan Luo, Sushan Luo, Jiahong Lu, Chongbo Zhao, Chongbo Zhao, Chongbo Zhao, Jie Lin, Jie Lin, Jie Lin   +27 more
doaj   +1 more source

Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP

BMC Neurology, 2017
Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is presented by a large heterogeneity of clinical phenotypes. Around 50% of patients suffer from typical CIDP and show better therapy response than atypical variants.
M. Staudt, J. M. Diederich, C. Meisel, A. Meisel, J. Klehmet   +4 more
doaj   +1 more source